The effect of nifedipine, Ca2+ antagonist, on activity of MAO inhibitors, N-acetylserotonin and melatonin in the mouse tail suspension test

International Journal of Neuropsychopharmacology

Volumn 1, Issue 1, 1998, Pages 35-40

  Prakhie, Irine V ^a   Oxenkrug, Gregory F ^b,c  

^a Bekhterev St Petersburg Psychoneurological Research Institute   (Russian Federation)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Antidepressants; C57BL 6 mice; MAO inhibitors; Melatonin; N acetylserotonin; Tail suspension test

Indexed keywords

EID: 0001978372     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145798001096     Document Type: Article

References (18)

1. Conti A, Maestroni GJM (1996). HPLC validation of a arcadian melatonin rhythm in the pineal gland of inbred mice. Journal of Pineal Research 20, 138-144.
2. De Vry J, Fritze J, Post R (1997). The management of coexisting depression in patients with dementia: potential of calcium channel antagonists. Clinical Neuropharmacology 20, 22-35.
3. Dubocovich ML, Mogilnicka E, Areso PM (1990). Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. European Journal of Pharmacology 182, 313-325.
4. Ebihara S, Marks T, Hudson DJ, Menaker M (1986). Genetic control of melatonin synthesis in the pineal gland of mouse. Science 231, 491-493.
5. Kozlovski VL, Prakhie IV (1994). Calcium channel blockers as antidepressants - a property of the class or the individual preparation? Experimental and Clinical Pharmacology (Russian), 57, 17-20.
6. Kozlovski VL, Prakhie IV (1996). The effect of calcium channel blockers on the activity of antidepressants in the mouse tail suspension test. Journal of Experimental and Clinical Pharmacology 59, 9-11.
7. Lapin IP, Oxenkrug GF (1970). The frog as a subject for screening thymoleptic drugs. Journal of Pharmacy and Pharmacology 22, 781-783.
8. O'Neill MF, Fernandes AG, Palacio JM (1996). GR127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test. Pharmacology, Biochemistry and Behavior 53, 535-539.
9. Oxenkrug G (1991). The acute effect of monoamine oxidase inhibitors on serotonin conversion to melatonin. In: Coppen A, Sandler M and Harnett S (Eds.) 5-Hydroxytryptamine and Mental Illness (pp. 99-108). New York, Oxford University Press.
10. Poursolt RD, McArtur RA, Lenegre A (1993). Psychotropic screning procedures. In: van Haaren F (Ed.) Models in Behavioral Pharmacology (pp. 23-50). Amsterdam, Elsevier Science Publishers.
11. Requintina PJ, Oxenkrug GF, Yuwiler A, Oxenkrug AG (1994). Synergistic sedative effect of selective MAO-A, but not MAO-B, inhibitors and melatonin in frogs. Journal of Neural Transmission (Supplement) 41, 141-144.
12. Rovei V, Caille D, Curet O, Ego D, Jarreau FX (1994). Biochemical pharmacology of befloxatone (MD 370503), a new potent, reversible MAO-A inhibitor. Journal of Neural Transmission (Supplement) 41, 339-347.
13. Siuciak JA, Fang J-M, Dubocovich ML (1990). Autoradiographic localization of 2[I-125] iodomelatonin binding sites in the brains of C3H/HeN and C57B1/6J strains of mice. European Journal of Pharmacology 180, 387-390.
14. Skene D, Potgieter B (1981). Investigation of two models of depression. South African Journal of Science 77, 180-182.
15. Steru L, Cherwat R, Thierry B, Mico J-A, Lenegre A, Steru M, Simon P, Poursolt RD (1987). The automated tail suspension test: a computerized device which differentiates psychotropic drugs. Progress in NeuroPsychopharmacology and Biological Psychiatry 11, 659-673.
16. Steru L, Cherwat R, Thierry B, Simon P (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85, 367-370.
17. Sugden D (1983). Psychopharmacological effects of melatonin in mouse and rat. Journal of Pharmacology and Experimental Therapeutics 227, 587-591.
18. Trulas R, Jackson B, Skolnick P (1989). Genetic differences in a tail suspension test for evaluating antidepressant activity. Psychopharmacology 99, 287-288.